Efficiency of antitumor screening relative to activity criteriaPAULL, K; HODES, L; SIMON, R. M et al.Journal of the National Cancer Institute. 1986, Vol 76, Num 6, pp 1137-1142, issn 0027-8874Article

ANTITUMOR AGENTS. LVI: THE PROTEIN SYNTHESIS INHIBITION BY GENKWADAPHNIN AND YUANHUACINE OF P-388 LYMPHOCYTIC LEUKEMIA CELLSLIOU YF; HALL IH; LEE KH et al.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 12; PP. 1340-1344; BIBL. 12 REF.Article

Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC = Comparaison de tests in vitro pour déceler les sous-populations de cellules leucémiques P388 résistantes à l'araCRAZA, A; KULICZKOWSKI, K; WEIDONG, G et al.Medical oncology and tumor pharmacotherapy. 1984, Vol 1, Num 3, pp 163-168, issn 0736-0118Article

Characterization of the activity of α/β-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compoundATASSI, G; DUMONT, P; VANHAELEN, C et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 9, pp 1187-1191, issn 0277-5379Article

Reversal of multidrug resistance by non-antitumor anthracycline analogsINABA, M; NAGASHIMA, K; SAKURAI, Y et al.Japanese journal of cancer research. 1984, Vol 75, Num 12, pp 1049-1052, issn 0910-5050Article

Vincristine-resistant P388 leukemia cells contain a large amount of calcium = Les cellules de leucémie P388 résistantes à la vincristine contiennent une grande quantité de calciumTSURUO, T; IIDA, H; TSUKAGOSHI, S et al.Gann. 1983, Vol 74, Num 5, pp 619-621, issn 0016-450XArticle

EXPERIMENTAL IN VIVO CROSS-RESISTANCE OF VINCA ALKALOID DRUGSMARAL R; BOURUT C; CHENU E et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 3; PP. 197-199; BIBL. 20 REF.Article

SYNTHESIS AND ANTITUMOR EFFECT OF NEW BIOLOGICAL ALKYLATING AGENTS, ISETHIONIC ACID ESTERSKAWAZOE Y; TAMURA N.1981; GANN; ISSN 0016-450X; JPN; DA. 1981; VOL. 72; NO 6; PP. 862-867; BIBL. 9 REF.Article

TUMOR INHIBITION BY METALLOCENES: ACTIVITY AGAINST LEUKEMIAIS AND DETECTION OF THE SYSTEMIC EFFECTKOEPF MAIER P; WAGNER W; HESSE B et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 6; PP. 665-669; BIBL. 11 REF.Article

NEW POTENTIAL CYTOTOXIC AND ANTITUMOR SUBSTANCES. III: IN VITRO EFFECT OF 3-BENZAZEPINE DERIVATIVES ON P388 CELLSFUSKA J; FUSKOVA A; PROKSA B et al.1980; NEOPLASMA; ISSN 0028-2685; CSK; DA. 1980; VOL. 27; NO 6; PP. 703-709; BIBL. 15 REF.Article

ALCALOIDES DES ANNONACEES. XXVIII: ALCALOIDES DE L'UVARIA CHAMAE P. BEAUV.LEBOEUF M; CAVE A.1980; PLANT. MED. PHYTOTHER.; ISSN 0032-0994; FRA; DA. 1980; VOL. 14; NO 3; PP. 143-147; ABS. ENG; BIBL. 19 REF.Article

CYTOTOXIC PRINCIPLES FROM THE SAP OF KALMIA LATIFOLIAMANCINI SD; EDWARDS JM.1979; J. NAT. PROD.; USA; DA. 1979; VOL. 42; NO 5; PP. 483-488; BIBL. 16 REF.Article

ANTITUMOR AGENTS. XXXVII: THE ISOLATION AND STRUCTURAL ELUCIDATION OF ISOHELENOL, A NEW ANTILEUKEMIC SESQUITERPENE LACTONE, AND ISOHELENALIN FROM HELENIUM MICROCEPHALUMSIMS D; KUO HSIUNG LEE; RONG YANG WU et al.1979; J. NAT. PROD.; USA; DA. 1979; VOL. 42; NO 3; PP. 282-286; BIBL. 9 REF.Article

Synthesis of 2H-pyran-2-one derivatives from matricaria esterPROKSA, B; UHRIN, D; FUSKA, J et al.Pharmazie. 1986, Vol 41, Num 10, pp 703-704, issn 0031-7144Article

Proposed structure of the cyclic peptide dolastatin 3, a powerful cell growth inhibitor, should be revisedHAMADA, Y; KOHDA, K; SHIOIRI, T et al.Tetrahedron letters. 1984, Vol 25, Num 46, pp 5303-5306, issn 0040-4039Article

Constituents of Couepia paraensisSANDUJA, R; ALAM, M; EULER, K. L et al.Journal of natural products (Print). 1983, Vol 46, Num 1, issn 0163-3864, 149Article

Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells = Ordre structural des lipides membranaires dans les cellules P388 sensibles et résistantes à la doxorubicineRAMU, A; GLAUBIGER, D; MAGRATH, I. T et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5533-5537, issn 0008-5472Article

ANTITUMOR EFFECTS OF NOVEL IMMUNOACTIVE PEPTIDES, FK-156 AND ITS SYNTHETIC DERIVATIVESIZUMI S; NAKAHARA K; GOTOH T et al.1983; JOURNAL OF ANTIBIOTICS; ISSN 0021-8820; JPN; DA. 1983; VOL. 36; NO 5; PP. 566-574; BIBL. 13 REF.Article

ANTITUMOR AGENTS XLVIII: STRUCTURE-ACTIVITY RELATIONSHIPS OF QUASSINOIDS AS A IN VITRO PROTEIN SYNTHESIS INHIBITORS OF P-388 LYMPHOCYTIC LEUKEMIA TUMOR CELL METABOLISMLIOU YF; HALL IH; OKANO M et al.1982; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 4; PP. 430-435; BIBL. 20 REF.Article

SYNTHESIS AND BIOLOGIC EVALUATION OF THE DOPAMINE ANALOG N-ACETYLDOPAMINE IN EXPERIMENTAL LEUKEMIA IN MICEWICK MM; MUI A.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 351-354; BIBL. 16 REF.Article

PYRIDONES AS POTENTIAL ANTITUMOR AGENTS. II: 4-PYRIDONES AND BIOISOSTERES OF 3-ACETOXY-2-PYRIDONEHWANG DR; PROCTOR GR; DRISCOLL JS et al.1980; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1980; VOL. 69; NO 9; PP. 1074-1076; BIBL. 10 REF.Article

THE MODE OF ACTION OF VINCA ALKALOIDSCSUKA O; SUGAR J; PALYI I et al.1980; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1980; VOL. 37; SUPPL. 1; PP. 82-87; BIBL. 8 REF.Article

CATECHOLAMINE ANALOGS AS POTENTIAL ANTITUMOR AGENTSDRISCOLL JS.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 12; PP. 1519-1521; BIBL. 26 REF.Article

WIKSTROMOL, ANTITUMOR LIGNAN FROM WIKSTROEMIA FOETIDA VAR. AAHUENSIS GRAY AND WIKSTROEMIA UVA-URSI GRAY (THYMELEACEAE)TORRANCE SJ; HOFFMANN JJ; COLE JR et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 5; PP. 664-665; BIBL. 4 REF.Article

ANTITUMOR ACTIVITY OF PLATINUM(II) COMPLEXES OF 1-AMINO-2-AMINOMETHYLCYCLOHEXANE ISOMERSKIDANI Y; OKAMOTO K; NOJI M et al.1978; GANN; JPN; DA. 1978; VOL. 69; NO 6; PP. 863-864; BIBL. 4 REF.Article